Thermo Fisher Scientific
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Overview
Thermo Fisher Scientific is a provider of laboratory information management and scientific data systems. It aims to enable its customers to make the world healthier, cleaner, and safer. Whether its customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies, or increasing productivity in their laboratories.Its global team delivers an unrivaled combination of innovative technologies, purchasing convenience, and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon.
Tech Stack
Funding History
Post Ipo Debt
$6.1B
Oct 2021
Post Ipo Debt
$736.1M
Oct 2022
Post Ipo Debt
$1.3B
Nov 2022
Grant
$500K
Mar 2023
National Grid
Post Ipo Debt
$3.0B
Aug 2023
Post Ipo Debt
$2.5B
Sep 2025
Post Ipo Debt
$2.4B
Nov 2025